American Journal of Medical Genetics: Difference between revisions
No edit summary |
Updated the entry to include some more information about part A of the journal and the successive editors of the journal. Hope this is helpful! |
||
| Line 40: | Line 40: | ||
Until 1996 they were one journal under the name ''American Journal of Medical Genetics'', when they split into Part A and Part B. Part C was established in 1999.<ref>{{cite web| url=https://www.nhsheroes.co.uk/| title=NHS Heroes }} Tuesday, 6 December 2016</ref> |
Until 1996 they were one journal under the name ''American Journal of Medical Genetics'', when they split into Part A and Part B. Part C was established in 1999.<ref>{{cite web| url=https://www.nhsheroes.co.uk/| title=NHS Heroes }} Tuesday, 6 December 2016</ref> |
||
Part A of the Journal focuses on specific domains within the discipline of medical genetics. Specifically, it is focused on the study of the cause and pathogenesis (including molecular analyses); delineation (including phenotype analyses, natural history, variability, nosology, and newly recognized syndromes); and management (including genetic counseling, care guidelines, and treatment) of human congenital anomalies and genetic disorders. While recognizing the existence of thousands of human genetic conditions, the Journal focuses on phenotypically-driven analyses of disorders of morphogenesis, metabolism, and neurogenetics, especially intellectual disability and related neurodevelopmental conditions. Other principal themes of the Journal include the epidemiology of congenital malformations, behavioral phenotypes of syndromes, and astute clinical observations. (adapted from the |
Part A of the Journal focuses on specific domains within the discipline of medical genetics. Specifically, it is focused on the study of the cause and pathogenesis (including molecular analyses); delineation (including phenotype analyses, natural history, variability, nosology, and newly recognized syndromes); and management (including genetic counseling, care guidelines, and treatment) of human congenital anomalies and genetic disorders. While recognizing the existence of thousands of human genetic conditions, the Journal focuses on phenotypically-driven analyses of disorders of morphogenesis, metabolism, and neurogenetics, especially intellectual disability and related neurodevelopmental conditions. Other principal themes of the Journal include the epidemiology of congenital malformations, behavioral phenotypes of syndromes, and astute clinical observations. (adapted from the |
||
The founding Editor in Chief of the Journal was John M. Opitz , the second Editor in Chief was John C. Carey, and the current Editor in Chief (Part A) is Dr. Maximilian Muenke. Dr. Carey continues as Editor in Chief of Part C. |
The founding Editor in Chief of the Journal was John M. Opitz , the second Editor in Chief was John C. Carey, and the current Editor in Chief (Part A) is Dr. Maximilian Muenke. Dr. Carey continues as Editor in Chief of Part C. |
||
Revision as of 22:06, 17 February 2017
| Discipline | Human genetics |
|---|---|
| Language | English |
| Edited by | A & C: John C. Carey, B: Ming T. Tsuang, Stephen Faraone |
| Publication details | |
| History | 1977–present |
| Publisher | Wiley-Liss (United States) |
| Frequency | 24/year |
| Standard abbreviations | |
| ISO 4 | Am. J. Med. Genet. |
| Indexing | |
Part A | |
| ISSN | 1552-4833 (print) 1552-4825 (web) |
Part B | |
| ISSN | 1552-4841 (print) 1552-485X (web) |
Part C | |
| ISSN | 1552-4868 (print) 1552-4876 (web) |
American Journal of Medical Genetics is a peer-reviewed medical journal dealing with human genetics published in three separate sections (parts) by Wiley-Liss:
- American Journal of Medical Genetics Part A
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Until 1996 they were one journal under the name American Journal of Medical Genetics, when they split into Part A and Part B. Part C was established in 1999.[1]
Part A of the Journal focuses on specific domains within the discipline of medical genetics. Specifically, it is focused on the study of the cause and pathogenesis (including molecular analyses); delineation (including phenotype analyses, natural history, variability, nosology, and newly recognized syndromes); and management (including genetic counseling, care guidelines, and treatment) of human congenital anomalies and genetic disorders. While recognizing the existence of thousands of human genetic conditions, the Journal focuses on phenotypically-driven analyses of disorders of morphogenesis, metabolism, and neurogenetics, especially intellectual disability and related neurodevelopmental conditions. Other principal themes of the Journal include the epidemiology of congenital malformations, behavioral phenotypes of syndromes, and astute clinical observations. (adapted from the
The founding Editor in Chief of the Journal was John M. Opitz , the second Editor in Chief was John C. Carey, and the current Editor in Chief (Part A) is Dr. Maximilian Muenke. Dr. Carey continues as Editor in Chief of Part C.
References
- ^ "NHS Heroes". Tuesday, 6 December 2016
External links
  | This article about a medical journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
 | This article about a genetics journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |